Covered recipient · General Payments record
MALLIKA KAMANA
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$3,687.65
- Reported across 188 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $601.29 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $242.45 | 13 |
| Melinta Therapeutics, Inc. | $91.55 | 5 |
| ViiV Healthcare Company | $74.69 | 4 |
| Insmed, Inc. | $69.42 | 3 |
| Shionogi Inc | $43.89 | 3 |
| Gilead Sciences, Inc. | $40.47 | 2 |
| Paratek Pharmaceuticals, Inc. | $22.93 | 1 |
| Retrophin, Inc. | $15.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.33 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023613 | CMS |
| ABBVIE INC. | $29.91 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023615 | CMS |
| ABBVIE INC. | $1.14 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023617 | CMS |
| ABBVIE INC. | $20.90 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023619 | CMS |
| ABBVIE INC. | $0.94 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023621 | CMS |
| ABBVIE INC. | $17.28 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023623 | CMS |
| ABBVIE INC. | $22.35 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023625 | CMS |
| ABBVIE INC. | $30.49 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023627 | CMS |
| ABBVIE INC. | $23.80 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023629 | CMS |
| ABBVIE INC. | $25.92 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023631 | CMS |
| ABBVIE INC. | $14.31 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023633 | CMS |
| ABBVIE INC. | $30.12 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023635 | CMS |
| ABBVIE INC. | $6.96 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104023637 | CMS |
| Gilead Sciences, Inc. | $17.61 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133822444 | CMS |
| Gilead Sciences, Inc. | $22.86 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133822446 | CMS |
| Insmed, Inc. | $22.55 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089577962 | CMS |
| Insmed, Inc. | $28.61 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089564606 | CMS |
| Insmed, Inc. | $18.26 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565137 | CMS |
| Melinta Therapeutics, LLC | $17.38 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140481284 | CMS |
| Melinta Therapeutics, LLC | $14.73 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140480044 | CMS |
| Melinta Therapeutics, LLC | $19.65 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140482362 | CMS |
| Melinta Therapeutics, LLC | $17.32 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140481258 | CMS |
| Melinta Therapeutics, LLC | $22.47 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140483712 | CMS |
| Paratek Pharmaceuticals, Inc. | $22.93 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113905553 | CMS |
| Shionogi Inc | $16.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154335166 | CMS |
| Shionogi Inc | $14.47 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154335174 | CMS |
| Shionogi Inc | $13.42 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154335192 | CMS |
| Travere Therapeutics, Inc. | $15.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149933591 | CMS |
| ViiV Healthcare Company | $18.53 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112732887 | CMS |
| ViiV Healthcare Company | $14.67 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112705530 | CMS |
| ViiV Healthcare Company | $20.92 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112806943 | CMS |
| ViiV Healthcare Company | $20.57 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112720254 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.